CD5 (T-cell Surface Glycoprotein CD5) (PerCP/Cy5.5)

Cat# 367104-200T

Size : 200Tests

Brand : US Biological

Contact local distributor :


Phone : +1 850 650 7790


367104CD5 (T-cell Surface Glycoprotein CD5) (PerCP/Cy5.5)

Specifications
Clone TypeMonoclonal
Hostmouse
Sourcehuman
Swiss ProtP06128
IsotypeIgG1,k
GradePurified
Accession #NM_014208
Shipping TempBlue Ice
Storage Temp4°C Do Not Freeze

CD5 is a 67kD protein and a member of the scavenger receptor cysteine-rich protein superfamily (SRCR).  It is expressed on T lymphocytes, thymocytes, and IgM-secreting B cells (B-1 cells).  

Applications:
Suitable for use in Flow Cytometry. Other applications not tested.

Recommended Dilution:
Flow Cytometry: 5ul is sufficient for staining of 1 million cells in a 100ul staining volume or 100ul of whole blood
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C. For long-term storage, aliquot and store at 4°C. Do not freeze. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer. PerCP conjugates are sensitive to light.

Applications
Product Type: Mab|Isotype: IgG1,k|Clone No: OKT1|Host: mouse|Source: human|Concentration: ~0.1mg/ml|Form: Supplied as a liquid in PBS, pH 7.2, 0.2% BSA, 0.09% sodium azide. Labeled with PerCP/Cy5.5. |Purity: Purified|Immunogen: Human peripheral blood lymphocytes|Specificity: Recognizes human CD5. ||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Immunogen
Human peripheral blood lymphocytes
Form
Supplied as a liquid in PBS, pH 7.2, 0.2% BSA, 0.09% sodium azide. Labeled with PerCP/Cy5.5.
Purity
Purified
Specificity
Recognizes human CD5.
References
1. Berney, S.M, et al. 2000. J Investig Med. 48:102. 2. Burastero, E.E, et al. 1989. Contrib Microbiol Immunol. 11:231. 3. Kung, P, et al 1979. Science. 206:347. 4. Tabbekh, M, et al. 2013. Oncoimmunology. 2:e22841.